Correlation Between Scpharmaceuticals and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Scpharmaceuticals and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Kalvista Pharmaceuticals.
Diversification Opportunities for Scpharmaceuticals and Kalvista Pharmaceuticals
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scpharmaceuticals and Kalvista is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Kalvista Pharmaceuticals. In addition to that, Scpharmaceuticals is 1.1 times more volatile than Kalvista Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about 0.05 per unit of volatility. If you would invest 517.00 in Kalvista Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 498.00 from holding Kalvista Pharmaceuticals or generate 96.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| Scpharmaceuticals |
| Kalvista Pharmaceuticals |
Scpharmaceuticals and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Kalvista Pharmaceuticals
The main advantage of trading using opposite Scpharmaceuticals and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |